Breast Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Breast Cancer > What Your Doctor is Reading About Breast Cancer > Review Articles

Review Articles

1. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

Author: Eisen A; Trudeau M; Shelley W; Messersmith H; Pritchard KI;
Institution: Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. andrea.eisen@sunnybrook.ca
Journal: Cancer Treat Rev. 2008 Apr;34(2):157-74. Epub 2007 Dec 31.
Abstract URL: Click here to view abstract

2. Advances in the treatment of breast cancer.

Author: Moulder S; Hortobagyi GN;
Institution: Department of Breast Medical Oncology and Phase I Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. smoulder@mdanderson.org
Journal: Clin Pharmacol Ther. 2008 Jan;83(1):26-36. Epub 2007 Dec 19.
Abstract URL: Click here to view abstract

3. Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Author: Lynch HT; Silva E; Snyder C; Lynch JF;
Institution: Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebraska 68178, USA. htlynch@creighton.edu
Journal: Breast J. 2008 Jan-Feb;14(1):3-13. Epub 2007 Dec 11.
Abstract URL: Click here to view abstract

4. Aromatase inhibitors in early hormone receptor-positive breast cancer : what is the optimal initiation time for the maximum benefit?

Author: Needleman SJ; Tobias JS;
Institution: Department of Oncology, University College Hospital, London, UK.
Journal: Drugs. 2008;68(1):1-15.
Abstract URL: Click here to view abstract

5. Subsequent pregnancy after breast cancer.

Author: Peccatori F; Cinieri S; Orlando L; Bellettini G;
Institution: Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy.
Journal: Recent Results Cancer Res. 2008;178:57-67.

6. Breast cancer during pregnancy: medical therapy and prognosis.

Author: Aebi S; Loibl S;
Institution: University Hospital Bern, Inselspital, Breast and Gynecologic Cancer Center, Switzerland.
Journal: Recent Results Cancer Res. 2008;178:45-55.

7. Oral contraceptive use and risk of breast cancer.

Author: Casey PM; Cerhan JR; Pruthi S;
Institution: Department of Obstetrics and Gynecology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. casey.petra@mayo.edu
Journal: Mayo Clin Proc. 2008 Jan;83(1):86-90; quiz 90-1.
Abstract URL: Click here to view abstract

8. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Author: Early Breast Cancer Trialists' Collaborative Group; Clarke M; Coates AS; Darby SC; Davies C; Gelber RD; Godwin J; Goldhirsch A; Gray R; Peto R; Pritchard KI; Wood WC;
Institution
Journal: Lancet. 2008 Jan 5;371(9606):29-40.
Abstract URL: Click here to view abstract

9. Recent advances in the hormonal treatment of breast cancer.

Author: Boughey JC; Buzdar AU; Hunt KK;
Institution: Mayo Clinic, Rochester, Minnesota, USA.
Journal: Curr Probl Surg. 2008 Jan;45(1):13-55.

10. Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions.

Author: Tonini G; Schiavon G; Fratto ME; Vincenzi B; Santini D;
Institution: University Campus Bio-Medico, Medical Oncology, Via Emilio Longoni, 83 00155 Rome, Italy. g.tonini@unicampus.it
Journal: Expert Opin Biol Ther. 2008 Feb;8(2):221-34.
Abstract URL: Click here to view abstract

11. Breast cancer during pregnancy: epidemiology, surgical treatment, and staging.

Author: Gentilini O;
Institution: Breast Surgery, European Institute of Oncology, Milan, Italy.
Journal: Recent Results Cancer Res. 2008;178:39-44.

12. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.

Author: O'Brien ME;
Institution: Royal Marsden Hospital, NHS Trust, Sutton, Surrey, UK. maryo'brien@rmh.nhs.uk
Journal: Anticancer Drugs. 2008 Jan;19(1):1-7.
Abstract URL: Click here to view abstract

13. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.

Author: Pruthi S; Boughey JC; Brandt KR; Degnim AC; Dy GK; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Ingle JN;
Institution: Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pruthi.sandhya@mayo.edu
Journal: Mayo Clin Proc. 2007 Sep;82(9):1131-40.
Abstract URL: Click here to view abstract

14. Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety.

Author: Lazaridis G; Pentheroudakis G; Pavlidis N;
Institution: Department of Medical Oncology, Ioannina University Hospital, Niarxou Avenue, 45500 Ioannina, Greece.
Journal: Crit Rev Oncol Hematol. 2008 Apr;66(1):31-41. Epub 2007 Sep 4.
Abstract URL: Click here to view abstract

15. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review.

Author: Lemieux J; Maunsell E; Provencher L;
Institution: Unite de recherche en sante des populations, Centre hospitalier affilie universitaire de Quebec, Quebec, Que, Canada. julie.lemieux@uresp.ulaval.ca
Journal: Psychooncology. 2008 Apr;17(4):317-28.
Abstract URL: Click here to view abstract

16. A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis.

Author: Pruthi S; Brandt KR; Degnim AC; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Dy GK; Ingle JN;
Institution: Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pruthi.sandhya@mayo.edu
Journal: Mayo Clin Proc. 2007 Aug;82(8):999-1012.
Abstract URL: Click here to view abstract

17. Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006.

Author: Ng R; Pond GR; Tang PA; MacIntosh PW; Siu LL; Chen EX; Ng R; Pond GR; Tang PA; MacIntosh PW; Siu LL; Chen EX;
Institution: Department of Medical Oncology and Hematology, Princess Margaret Hospital, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Journal: Ann Oncol. 2008 Mar;19(3):481-6. Epub 2007 Nov 20.
Abstract URL: Click here to view abstract

18. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.

Author: Dodwell D; Williamson D;
Institution: Cookridge Hospital, Hospital Lane, Leeds LS16 6QB, UK. David.Dodwell@leedsth.nhs.uk
Journal: Cancer Treat Rev. 2008 Apr;34(2):137-44. Epub 2007 Nov 14.
Abstract URL: Click here to view abstract

19. Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

Author: Dean-Colomb W; Esteva FJ;
Institution: The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. festeva@mdanderson.org
Journal: Semin Oncol. 2008 Apr;35(2 Suppl 2):S31-8; quiz S40.
Abstract URL: Click here to view abstract

20. Clinical studies with epothilones for the treatment of metastatic breast cancer.

Author: Vahdat LT;
Institution: Division of Hematology/Oncology, Weill Medical College of Cornell University, New York, NY 20021. ltv2001@med.cornell.edu
Journal: Semin Oncol. 2008 Apr;35(2 Suppl 2):S22-30; quiz S40.
Abstract URL: Click here to view abstract

21. The molecular journey from ductal carcinoma in situ to invasive breast cancer.

Author: Wiechmann L; Kuerer HM; Wiechmann L; Kuerer HM;
Institution: Breast Center, Baylor College of Medicine, Houston, Texas, USA.
Journal: Cancer. 2008 May 15;112(10):2130-42.
Abstract URL: Click here to view abstract

22. Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.

Author: Metro G; Fabi A; Russillo M; Papaldo P; De Laurentiis M; Ferretti G; Pellegrini D; Nuzzo C; Graziano V; Vici P; Introna M; Felici A; Cognetti F; Carlini P;
Institution: Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy.
Journal: Anticancer Res. 2008 Mar-Apr;28(2B):1245-58.
Abstract URL: Click here to view abstract

23. Breast cancer in young women.

Author: Axelrod D; Smith J; Kornreich D; Grinstead E; Singh B; Cangiarella J; Guth AA;
Institution: Department of Surgery, New York University School of Medicine, New York, NY, USA.
Journal: J Am Coll Surg. 2008 Jun;206(3):1193-203. Epub 2008 Apr 24.

24. Ixabepilone: a new microtubule-targeting agent for breast cancer.

Author: Higa GM; Abraham J;
Institution: Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA.
Journal: Expert Rev Anticancer Ther. 2008 May;8(5):671-81.
Abstract URL: Click here to view abstract

25. Raloxifene in breast cancer prevention.

Author: Gennari L; Merlotti D; Paola VD; Nuti R;
Institution: University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Viale Bracci 1, 53100 Siena, Italy. gennari@unisi.it
Journal: Expert Opin Drug Saf. 2008 May;7(3):259-70.
Abstract URL: Click here to view abstract

26. Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.

Author: Journe F; Body JJ; Leclercq G; Laurent G;
Institution: Universite Libre de Bruxelles (ULB), Laboratory of Endocrinology and Bone Diseases, Institut Jules Bordet, Rue Heger-Bordet 1, 1000 Brussels, Belgium. fabrice.journe@bordet.be
Journal: Expert Opin Drug Saf. 2008 May;7(3):241-58.
Abstract URL: Click here to view abstract

27. Overview of breast cancer staging and surgical treatment options.

Author: Hammer C; Fanning A; Crowe J;
Institution: Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Journal: Cleve Clin J Med. 2008 Mar;75 Suppl 1:S10-6.
Abstract URL: Click here to view abstract

28. Pharmacotherapy of bone metastases in breast cancer patients.

Author: Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M;
Institution: Resident, Internal Medicine University of Toronto, Department of Medicine, 190 Elizabeth Street, Toronto, Ontario, M5G2C4, Canada.
Journal: Expert Opin Pharmacother. 2008 Apr;9(6):937-45.
Abstract URL: Click here to view abstract

29. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.

Author: Carpenter R;
Institution: St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. robert.carpenter@bartsandthelondon.nhs.uk
Journal: Eur J Surg Oncol. 2008 Jul;34(7):746-55. Epub 2008 Mar 4.
Abstract URL: Click here to view abstract

30. Major depression after breast cancer: a review of epidemiology and treatment.

Author: Fann JR; Thomas-Rich AM; Katon WJ; Cowley D; Pepping M; McGregor BA; Gralow J;
Institution: Department of Psychiatry and Behavioral Sciences, University of Washington, P.O. Box 356560, Seattle, WA 98195, USA. fann@u.washington.edu
Journal: Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26.
Abstract URL: Click here to view abstract

31. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.

Author: Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP;
Institution: Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcolmbe Blvd, Unit 1202, Houston, TX 77030, USA. tbuchhol@mdanderson.org
Journal: J Clin Oncol. 2008 Feb 10;26(5):791-7.
Abstract URL: Click here to view abstract

32. Locally advanced and inflammatory breast cancer.

Author: Chia S; Swain SM; Byrd DR; Mankoff DA;
Institution: Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Ave, Vancouver, British Columbia, Canada. schia@bccancer.bc.ca
Journal: J Clin Oncol. 2008 Feb 10;26(5):786-90.

33. Implementing a survivorship care plan for patients with breast cancer.

Author: Ganz PA; Hahn EE;
Institution: Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Room A2-125 CHS, Los Angeles, CA 90095-6900, USA. pganz@ucla.edu
Journal: J Clin Oncol. 2008 Feb 10;26(5):759-67.
Abstract URL: Click here to view abstract

34. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

Author: Parton M; Smith IE;
Institution: Breast Unit, The Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom.
Journal: J Clin Oncol. 2008 Feb 10;26(5):745-52.

35. Breast cancer and sexuality.

Author: Sheppard LA; Ely S;
Institution: University of South Australia, Adelaide, South Australia, Australia. lorraine.sheppard@unisa.edu.au
Journal: Breast J. 2008 Mar-Apr;14(2):176-81. Epub 2008 Jan 31.
Abstract URL: Click here to view abstract

36. Trastuzumab as the lead monoclonal antibody in advanced breast cancer: choosing which patient and when.

Author: Olver IN;
Institution: The Cancer Council Australia, Level 1, 120 Chalmers Street, Surry Hills, NSW 2010, Australia. ian.olver@cancer.org.au
Journal: Future Oncol. 2008 Feb;4(1):125-31.
Abstract URL: Click here to view abstract

37. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.

Author: Nahleh Z;
Institution: Wayne State University, Karmanos Cancer Institute, 4100 John R, 4HWCRC, Detroit, MI 48201, USA. nahlehz@karmanos.org
Journal: Future Oncol. 2008 Feb;4(1):15-21.
Abstract URL: Click here to view abstract

38. Aromatase inhibitors in early breast-cancer treatment: The story so far.

Author: Cuzick J;
Institution: Cancer Research UK, Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK. jack.cuzick@cancer.org.uk
Journal: Breast. 2008 Apr;17 Suppl 3:S2-8.
Abstract URL: Click here to view abstract

39. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.

Author: Minisini AM; Andreetta C; Fasola G; Puglisi F;
Institution: University and General Hospital of Udine, Department of Oncology, Udine, Italy. minisini.alessandro@aoud.sanita.fvg.it
Journal: Expert Rev Anticancer Ther. 2008 Mar;8(3):331-42.
Abstract URL: Click here to view abstract

40. Ixabepilone, a novel epothilone analog in the treatment of breast cancer.

Author: Pivot X; Villanueva C; Chaigneau L; Nguyen T; Demarchi M; Maurina T; Stein U; Borg C;
Institution: Oncologie Medicale, CHU J Minjoz, 25000 Besancon, France. xavier.pivot@univ-fcomte.fr
Journal: Expert Opin Investig Drugs. 2008 Apr;17(4):593-9.
Abstract URL: Click here to view abstract

41. Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer.

Author: Chia S; Gradishar W;
Institution: Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. SChia@bccancer.bc.ca
Journal: Breast. 2008 Apr;17 Suppl 3:S16-21. Epub 2008 Mar 18.
Abstract URL: Click here to view abstract

42. Breast reconstruction in a changing breast cancer treatment paradigm.

Author: Warren AG; Morris DJ; Houlihan MJ; Slavin SA;
Institution: Division of Plastic Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass., USA.
Journal: Plast Reconstr Surg. 2008 Apr;121(4):1116-26.

43. Clinical practice. Management of an inherited predisposition to breast cancer.

Author: Robson M; Offit K;
Institution: Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York 10021, USA. robsonm@mskcc.org
Journal: N Engl J Med. 2007 Jul 12;357(2):154-62.

44. Diet and breast cancer: a review of the prospective observational studies.

Author: Michels KB; Mohllajee AP; Roset-Bahmanyar E; Beehler GP; Moysich KB;
Institution: Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. kmichels@rics.bwh.harvard.edu
Journal: Cancer. 2007 Jun 15;109(12 Suppl):2712-49.
Abstract URL: Click here to view abstract

45. Controversies in preservation of ovary function and fertility in patients with breast cancer.

Author: Gerber B; Dieterich M; Muller H; Reimer T;
Institution: Department of Gynecology and Obstetrics, University of Rostock, Klinikum Sudstadt Rostock, Sudring 81, Rostock, Germany. bernd.gerber@med.uni-rostock.de
Journal: Breast Cancer Res Treat. 2008 Mar;108(1):1-7. Epub 2007 Apr 25.
Abstract URL: Click here to view abstract

46. Screening for breast cancer: current recommendations and future directions.

Author: Knutson D; Steiner E;
Institution: The Ohio State University, Department of Family Medicine, Columbus, Ohio 43201, USA. doug.knutson@osumc.edu
Journal: Am Fam Physician. 2007 Jun 1;75(11):1660-6.
Abstract URL: Click here to view abstract

47. Clinical practice. Follow-up of patients with early breast cancer.

Author: Hayes DF;
Institution: University of Michigan Comprehensive Cancer Center, Ann Arbor 48109, USA. hayesdf@umich.edu
Journal: N Engl J Med. 2007 Jun 14;356(24):2505-13.

48. Local therapy and survival in breast cancer.

Author: Punglia RS; Morrow M; Winer EP; Harris JR;
Institution: Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. rpunglia@lroc.harvard.edu
Journal: N Engl J Med. 2007 Jun 7;356(23):2399-405.

49. Gemcitabine in the management of metastatic breast cancer: a systematic review.

Author: Dent S; Messersmith H; Trudeau M;
Institution: The Ottawa Hospital Regional Cancer Centre, Ottawa, Canada.
Journal: Breast Cancer Res Treat. 2008 Apr;108(3):319-31. Epub 2007 May 26.
Abstract URL: Click here to view abstract

50. Breast cancer in pregnancy: a literature review.

Author: Molckovsky A; Madarnas Y;
Institution: Department of Oncology, Queen's University, Kingston, ON, Canada.
Journal: Breast Cancer Res Treat. 2008 Apr;108(3):333-8. Epub 2007 May 26.
Abstract URL: Click here to view abstract

51. Multidisciplinary frontiers in breast cancer management: a surgeon's perspective.

Author: Singletary SE;
Institution: Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Journal: Cancer. 2007 Feb 12;.
Abstract URL: Click here to view abstract

52. Prevention of venous thromboembolism in surgical patients with breast cancer.

Author: Patiar S; Kirwan CC; McDowell G; Bundred NJ; McCollum CN; Byrne GJ;
Institution: Department of Surgery, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK.
Journal: Br J Surg. 2007 Apr;94(4):412-20.
Abstract URL: Click here to view abstract